Home › NDC Lookup › RxCUI directory › RxCUI 2110510

60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inha... — RxCUI 2110510

RxNorm drug concept · Semantic branded drug
RxCUI 2110510 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2110510
Official name60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asWixela Inhub 100/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)90,097 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluticasone Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — fluticasone is a preventive inhaler, not a rescue inhaler. It works by slowly reducing airway inflammation over days to weeks, so it won't open your airways fast enough during...
  • Can I use my fluticasone inhaler when I'm having an asthma attack?
  • Great question — this is one of the most practical things you can do. When you inhale fluticasone, some of the medication can land in your mouth and throat rather than making it al...
  • Why do I need to rinse my mouth after using it?
📖 Read our full Fluticasone Oral Inhalation guide →

🕸️ Concept Web — How 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] RxCUI 2110510

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Fluticasone 41126
    • Salmeterol 36117
    • Fluticasone / salmeterol 284635
    • Fluticasone propionate 50121
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Wixela 2110506
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluticasone / salmeterol Dry Powder Inhaler 746717
    • Fluticasone propionate / salmeterol Dry Powder Inhaler 2647498
    • Fluticasone / salmeterol Inhalant Product 1165654
    • Fluticasone propionate / salmeterol Inhalant Product 2660442
    • Fluticasone / salmeterol Dry Powder Inhaler [Wixela] 2110508
    • Fluticasone propionate / salmeterol Dry Powder Inhaler [Wixela] 2656754
    • Wixela Inhalant Product 2110509
    • Dry Powder Inhaler 744995
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT [Wixela] SBDC · 2110507
  • Fluticasone / salmeterol Dry Powder Inhaler [Wixela] SBDF · 2110508
  • Fluticasone propionate / salmeterol Dry Powder Inhaler [Wixela] SBDFP · 2656754
  • Wixela Inhalant Product SBDG · 2110509
  • Wixela BN · 2110506

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2110510 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-9320-32 1 INHALER in 1 CARTON (0378-9320-32) / 60 POWDER in 1 INHAL... Wixela Inhub Mylan Pharmaceuticals Inc. 2019-02-11
00378-9321-32 1 INHALER in 1 CARTON (0378-9321-32) / 60 POWDER in 1 INHAL... Wixela Inhub Mylan Pharmaceuticals Inc. 2019-02-11
00378-9322-32 1 INHALER in 1 CARTON (0378-9322-32) / 60 POWDER in 1 INHAL... Wixela Inhub Mylan Pharmaceuticals Inc. 2019-02-11
Observed labelers: Mylan Pharmaceuticals Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.